Anti-HBV activity of TRL mediated by recombinant adenovirus

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 17

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

217

HTML

1649

Figures (1-5)

348

Sum=2214

May 7, 2005 (publication date) through Feb 14, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Viral Hepatitis

World J Gastroenterol. May 7, 2005; 11(17): 2574-2578
Published online May 7, 2005. doi: 10.3748/wjg.v11.i17.2574

Full Size Figure Download Figure

Figure 2 The cytopathic effect of HEK293 cells. A: normal HEK293 cells; B: CPE of HEK293.

Citation: Gong WD, Zhao Y, Yi J, Ding J, Liu J, Xue CF. Anti-HBV activity of TRL mediated by recombinant adenovirus. World J Gastroenterol 2005; 11(17): 2574-2578
URL: https://www.wjgnet.com/1007-9327/full/v11/i17/2574.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i17.2574